In the face of contradictory evidence: Report of the Dietary Guidelines for Americans Committee
Article Outline
- Abstract
- Introduction
- Strong recommendations, weak evidence
- Macronutrient proportion and health outcomes
- Macronutrients: Research questions are formulated in a way that prevents a thorough investigation of the literature
- Macronutrients and weight loss: Science is inaccurately summarized
- Low-carbohydrate diets: Science is inaccurately represented
- Low-carbohydrate diets: Conclusions do not reflect quantity and/or quality of relevant science
- Dietary fat and health outcomes
- Effects of saturated fat: Answers based on an incomplete body of relevant science
- Effects of saturated fat: Science is inaccurately represented or summarized
- Diabetes and fat: Science is inaccurately represented or summarized
- Dietary carbohydrate and health outcomes
- Dietary fiber and whole grains: Conclusions do not reflect the quantity and/or quality of science
- Glycemic load/index: Answers based on an incomplete body of relevant science
- Dietary protein and health outcomes
- Animal versus plant protein: Recommendations do not reflect limitations and uncertainties of the science
- Salt: Recommendations do not reflect limitations and uncertainties of the science
- Summary: What can be done?
- Acknowledgments
- References
- Copyright
Abstract
Concerns that were raised with the first dietary recommendations 30 y ago have yet to be adequately addressed. The initial Dietary Goals for Americans (1977) proposed increases in carbohydrate intake and decreases in fat, saturated fat, cholesterol, and salt consumption that are carried further in the 2010 Dietary Guidelines Advisory Committee (DGAC) Report. Important aspects of these recommendations remain unproven, yet a dietary shift in this direction has already taken place even as overweight/obesity and diabetes have increased. Although appealing to an evidence-based methodology, the DGAC Report demonstrates several critical weaknesses, including use of an incomplete body of relevant science; inaccurately representing, interpreting, or summarizing the literature; and drawing conclusions and/or making recommendations that do not reflect the limitations or controversies in the science. An objective assessment of evidence in the DGAC Report does not suggest a conclusive proscription against low-carbohydrate diets. The DGAC Report does not provide sufficient evidence to conclude that increases in whole grain and fiber and decreases in dietary saturated fat, salt, and animal protein will lead to positive health outcomes. Lack of supporting evidence limits the value of the proposed recommendations as guidance for consumers or as the basis for public health policy. It is time to reexamine how US dietary guidelines are created and ask whether the current process is still appropriate for our needs.
Keywords: Evidence-based medicine, Saturated fat, Salt, Carbohydrate, Whole grain, Fiber, Protein, Dietary guidelines
Introduction
What is required is less advice and more information.
—Gerald M. Reaven [1]
There is little disagreement that we have a nutritional crisis in the United States. One manifestation is confusion in the mind of the public as to what constitutes sound principles [2], [3]. Recent scientific advances have not led to consensus, but rather to substantial disagreement among experts and further uncertainty for the public. Nutritional health covers a wide range of concerns but foremost in the mind of the public are whether the standing recommendations for lowering fat intake and increasing carbohydrate intake were ever appropriate for the prevention of obesity, diabetes, and cardiovascular disease; whether the regulation of carbohydrates is more important; and what the role of protein, especially from animal sources, should be in the diet. These concerns were raised with the first national dietary recommendations 30 y ago and have yet to be adequately addressed even as the nutritional health of Americans continues to decline.
The 2010 Dietary Guidelines Advisory Committee (DGAC) Report [4], released on June 15, 2010, was expected to address these issues (sections of the report are indicated as part-section number, e.g., B2; pages in the report are denoted, e.g., B2-3.). The DGAC Report had the opportunity to review and evaluate the emerging science, to distinguish between established principles and ideas that are still areas of research or controversy, and to provide clear, consistent information for Americans. Instead, the 2010 DGAC Report continues to make one-size-fits-all recommendations that are based on evidence that is weak, fragmented, and even contradictory in nature.
Strong recommendations, weak evidence
Important aspects of the recommendations remain unproven. The DGAC Report provides several examples in the summary of “Needs for Future Research” in each section. In the carbohydrates section, a goal of that research would be to:
However, the DGAC Report’s summary statement on carbohydrates is unambiguous in the face of these inconsistencies:
In the absence of research that can explain the mechanisms that would account for a beneficial effect of high carbohydrates on health outcomes, the recommendation must be considered premature.
The protein section includes a call for future research that will:
Yet the DGAC Report’s recommendations suggest no such limitations. Americans are told to:
The admission that health benefits from such a shift remain unknown and the acknowledgement of “potential limitations of [a] plant-based diet for key nutrients” (p. D4-31) would suggest that such a recommendation be made with more circumspection.
The DGAC Report calls for a general increase in whole grain consumption:
However, the DGAC Report also calls for additional research to:
Urging an increase in whole grain consumption before the term is consistently defined stymies any practical attempts to apply this recommendation.
These examples illustrate the general pattern of the DGAC Report: strong recommendations are made with weak and inconclusive evidence to support them. Conclusions rest on evidence-based methodology, embodied in the creation of the Nutrition Evidence Library (NEL). In practice, the methodology and the utilization of the NEL demonstrate several critical weaknesses:
The initial Dietary Goals for Americans (1977) proposed that Americans increase carbohydrate intake and decrease fat, saturated fat, cholesterol, and salt consumption, recommendations that are carried further in the proposed 2010 guidelines. Thirty years ago, critics argued “that the value of dietary change remains controversial and that science cannot at this time insure that an altered diet will provide improved protection from certain killer diseases” [5]. The proposed recommendations raise these same concerns. What remains of value in the current DGAC Report is substantially undermined by a failure to address these ongoing criticisms.
Macronutrient proportion and health outcomes
A consistent theme in the 2010 DGAC Report is the statement that “very few American children or adults currently follow the US Dietary Guidelines” (p. D1-8) and that “the primary focus should be on reducing excessive calorie intake” (p. B2-3). However, according to the DGAC Report, caloric intake remains within recommended levels, and leisure-time physical activity has increased slightly (pp. D1-1, B2-3). Adult women on average consume at the lowest end of the recommended calorie range and yet are the most overweight/obese (p. D1-4). The macronutrient proportions of the typical American diet fall within recommended ranges (p. D1-1): Americans currently consume less than 35% of their calories as fat and less than 300 mg of cholesterol per day (p. D3-10).
Americans are consuming more calories than in the past, but the increase has not been equally distributed across food groups. The increase in calories in the American diet over the previous 30 y is primarily due to carbohydrate intake (Fig. 1). Average daily calories from meat, eggs, and nuts have increased by about 20 cal since 1970 as average daily calories from flour and cereal products have increased by nearly 10 times that amount (p. D1-10). In short, the macronutrient content of the diet has shifted in the direction recommended since the 1977 dietary goals. Total and saturated fat intakes have decreased as a percentage of calories—for men, the absolute amount has decreased—whereas carbohydrate intake has increased [6]. Notable from the DGAC Report is the absence of any concern that this shift in macronutrient content may be a factor in the increase in overweight/obesity and chronic disease; the proposed recommendations suggest that this trend should not only continue but also become more pronounced.

Fig. 1
Energy intake during the epidemic of obesity. CHO, carbohydrate; NHANES, National Health and Nutrition Examination Survey; PROT, protein.
Data from the Centers for Disease Control and Prevention [6].
Macronutrients: Research questions are formulated in a way that prevents a thorough investigation of the literature
The 2005 Institute of Medicine Macronutrient Report states, “Compared to higher-fat diets, low-fat, high-carbohydrate diets may modify the metabolic profile in ways that are considered to be unfavorable with respect to chronic diseases such as coronary heart disease (CHD) and diabetes” [7]. The DGAC Report precludes the evaluation of the potential impact of high dietary carbohydrate on chronic disease by the way that research questions are formulated. The “Search Plan and Results” for the macronutrient section of the NEL excluded studies that have demonstrated the effect of macronutrient content on any metabolic response beyond weight loss [8], [9], [10], [11]. Also excluded were studies on the relation of macronutrient content to health outcomes or risk factors for chronic disease, even when weight was measured [12], [13], [14]. The DGAC Report only addresses the relation of chronic disease in regard to “dietary energy density” as measured in calories per gram, disregarding the overall nutrient content of foods entirely. Foods with low energy density are preferred in the DGAC Report, effectively leading to a bias in favor of lower-fat foods. It is the arbitrary exclusion of evidence, however, that decreases the potential for insights into improving the health of Americans.
Macronutrients and weight loss: Science is inaccurately summarized
Obesity and weight control are reasonably a major focus of the guidelines. However, the DGAC Report is hampered in its assessment of this issue by the common but overly simplified concept of weight loss as only a function of “calories in” versus “calories out.” In its answer to the question, “What is the relationship between macronutrient proportion and body weight in adults?” the DGAC Report concludes that:
The NEL contains evidence that is not consistent with this conclusion; several included studies show that a low-carbohydrate diet can produce significantly greater weight loss than a low-fat diet, even when caloric intake is held constant between diets [15], [16], [17], [18]. Figure 2 shows results from a study by Volek et al. [15] demonstrating greater weight loss on a low-carbohydrate diet compared with a low-fat diet, with similar caloric intake. Several studies in the NEL demonstrate equivalent or increased weight loss on low-carbohydrate diets that do not explicitly control calories or impose restrictive eating behaviors [15], [19], [20], [21], [22], [23], [24]. A full assessment of the science would recognize these departures from the stated conclusion.
Data from Volek et al. [15].
The DGAC Report goes on to conclude that:
This conclusion does not accurately reflect the research reviewed in the DGAC Report:
It is not clear what “moderate amount of evidence” means in this context; 47% of the cited studies demonstrate that low-carbohydrate or high-protein diets, whether hypocaloric or otherwise, are in fact more effective. A responsibly worded summary would acknowledge these contradictory findings.
Low-carbohydrate diets: Science is inaccurately represented
Low-carbohydrate diets are not recommended because they are “difficult to maintain over the long term.” Table 1 presents data from studies and meta-analyses included in the NEL showing that attrition rates are, if anything, lower for low-carbohydrate diets compared with low-fat diets [25], [26], [27], [28], [29], [30], [31]. An appropriate summary on adherence would state this. The DGAC Report suggests that the diet recommended in the current guidelines is difficult to follow (pp. D1-8, B3-4); the evidence demonstrates that some Americans may find a low-carbohydrate diet less so.
Table 1. Comparison of attrition rates between low-fat and low-carbohydrate diets
| Attrition (%) | ||
|---|---|---|
| Study | Low-fat diet | Low-carbohydrate diet |
| Yancy et al., 2004 [25] | 45 | 24 |
| Gardner et al., 2007 [26] | 22 | 12 |
| Samaha et al., 2003 [27] | 47 | 33 |
| Dansinger et al., 2005 [28] | 50 | 48 |
| Brehm et al., 2003 [29] | 26 | 15 |
| Foster et al., 2003 [30] | 43 | 39 |
| Tay et al., 2008 [31] | 18 | 20 |
Low-carbohydrate diets: Conclusions do not reflect quantity and/or quality of relevant science
The DGAC Report’s conclusions also maintain that diets that stray from the recommended guidelines “may be less safe,” a claim made about low-carbohydrate diets for 40 y without supporting data. The DGAC Report relies on two studies that “found that diets lower in carbohydrate and higher in protein were associated with increased total and cardiovascular mortality” [32], [33] (p. D1-49). Both studies have considerable flaws. In Lagiou et al. [32], which the NEL gives a “neutral” quality rating, dietary assessment was made at baseline and total and cardiovascular mortalities were determined up to 12 y later, a significant weakness. The study by Trichopoulou et al. [33] is a cohort study where the study population was distributed into quartiles according to low-carbohydrate/high-protein diet score. The investigators noted that, “In our study population, consumption of carbohydrates, even at the low extreme of the distribution, was higher than that advocated by the prescribed low-carbohydrate diets and few individuals consumed more than 20% of their energy from proteins” [33]. A similar conclusion was reached by Lagiou et al. [32].
More studies in the NEL demonstrate that low-carbohydrate diets improve CVD risk markers than demonstrate the opposite. The DGAC Report cites two studies that found increased low-density lipoprotein cholesterol in the low-carbohydrate arm. Six studies from the NEL that are not mentioned in the conclusions of the DGAC Report demonstrate the reliable increase in high-density lipoprotein cholesterol and the reliable and usually dramatic decrease in triacylglycerols that occur in response to carbohydrate restriction [19], [20], [21], [31], [34], [35]. One of these [19] is a meta-analysis of 13 studies that compared the weight-loss effects of low-carbohydrate diets against low-fat diets. The NEL summary of this meta-analysis concludes:
An objective assessment of the evidence from the NEL does not suggest the conclusive proscription against low-carbohydrate diets given in the DGAC Report’s conclusion; unsubstantiated dangers are exaggerated and consistent benefits are omitted.
Dietary fat and health outcomes
Prevention of chronic disease by manipulation of dietary fat and carbohydrate is a primary focus of the DGAC Report, although, as described above, evidence on the effects of macronutrient proportion on diseases is excluded. The section, “The Influence of Dietary Fats on Cardiovascular Disease (CVD) And Other Health Outcomes,” asks the question, “What is the effect of saturated fat intake on increased risk of cardiovascular disease or type 2 diabetes [T2D], including effects on intermediate markers such as serum lipid and lipoprotein levels?” (p. D3-15).
Effects of saturated fat: Answers based on an incomplete body of relevant science
The DGAC Report concludes that:
This conclusion is based on an incomplete body of relevant science. Only studies that measure the effects of SFA in the presence of recommended levels of dietary carbohydrate are included in the “Search Plan and Results” section of the NEL; studies with a low-carbohydrate intake are specifically excluded [15], [35], [36], [37], [38], [39], [40]. No mention is made of a recent large meta-analysis that found there is no substantial evidence for concluding that dietary saturated fat is associated with an increased risk of heart disease [41]. Not discussed are basic science studies demonstrating that plasma saturated fat, the presumed cause for concern, is substantially determined by dietary carbohydrate [40], [42].
Table 2 presents the effect on cardiovascular risk markers of total and saturated fat [15], [26], [27], [28], [43], [44]. The data, from studies and meta-analyses included in the NEL and elsewhere, show that when participants switched from their habitual diet to a low-carbohydrate diet (<45% of calories), neither total fat nor saturated fat consumption changed significantly, whereas positive changes occurred in cardiovascular risk markers. These findings are inconsistent with concerns regarding fat, specifically saturated fat. A comprehensive assessment of the science would necessarily result in a conclusion that addresses this inconsistency.
Table 2. Cardiovascular risk markers decrease and absolute fat and saturated fat are constant
| Study duration | Total fat (g/d) | Saturated fat (g/d) | Markers of cardiovascular risk (% change) | |||||
|---|---|---|---|---|---|---|---|---|
| Study | Habitual | End of study | Habitual | End of study | LDL | HDL | Triacylglycerol | |
| Gardner et al., 2007 [26] | 12 mo | 76 | 79 | 27 | 27 | +1 | +9 | −23 |
| Samaha et al., 2003 [27] | 6 mo | 77 | 74 | NR | NR | +4 | 0 | −20 |
| Dansinger et al., 2005 [28] | 12 mo | 78 | 81 | 26 | 27 | −5 | +7 | −1 |
| Brehm et al., 2005 [43] | 4 mo | 87 | 88 | NR | NR | −2 | +16 | −37 |
| Yancy et al., 2010 [44] | 48 wk | 105 | 107 | 34 | 38 | −2 | +10 | −19 |
| Volek et al., 2009 [15] | 12 wk | 97 | 100 | 34 | 37 | +4 | +11 | −51 |
Effects of saturated fat: Science is inaccurately represented or summarized
The conclusion of the DGAC Report suggests that the replacement of SFA with monounsaturated fatty acids or PUFA creates unequivocally positive cardiovascular risk factor outcomes; this is not the case. Studies cited by the DGAC Report demonstrate increases in atherogenic lipoprotein levels or triacylglycerols, decreases in high-density lipoprotein cholesterol, and varied metabolic responses to lowered dietary SFA in subpopulations [45], [46], [47], [48]. These controversies and uncertainties with regard to SFA are not included in the DGAC Report.
Citing a meta-analysis by Jakobsen et al. [49] as evidence of “a significant inverse association for PUFA (with 5% substitution for SFA) and coronary events” (p. D3-16), the DGAC Report misrepresents the actual findings of the meta-analysis. The NEL summary shows this association was weak overall and significant only for women younger than 60 y. The meta-analysis [49] also showed that for all men in the study and for women at least 60 y of age, there was no significant association between substitution of PUFA for SFA and risk of coronary events or coronary death. An accurate summary of this meta-analysis and the additional controversies and uncertainties in the science suggest that evidence associating dietary SFA with increased risk of CVD is inconclusive.
Diabetes and fat: Science is inaccurately represented or summarized
With regard to diabetes, the DGAC Report concludes that:
This statement shows the same disregard for physiologic mechanisms as before: all effects of saturated fat are measured in the presence of recommended (high) levels of carbohydrate intake. Because digestible dietary carbohydrate is the primary source of exogenous glucose, discounting the role of carbohydrate in the risk of T2D shows a troubling disregard for physiologic mechanisms. Regulating carbohydrate intake remains a primary strategy for achieving glycemic control [50], yet no studies with decreased carbohydrate intake were included.
The DGAC Report focuses instead on numerous studies investigating possible associations between T2D and SFA (p. D3-18). Two of these studies were, according to the DGAC Report:
However, 12 of 15 studies reviewed in Galgani et al. [51] found no effect relating to fatty acid type on insulin sensitivity, and Hu et al. [52] concluded that “dietary recommendations to prevent Type II diabetes should focus more on the quality of fat and carbohydrate in the diet than quantity alone.” Remaining studies are limited in their value for general application by multiple intervention factors applied simultaneously [53], [54], small sample size [55], [56], or assessment of subsets of various SFA or other specific fatty acids [57], [58], [59]. Similar studies showed mixed or inconclusive results [60], [61], [62].
The studies gathered in the NEL do not provide sufficient evidence to conclude that a decrease in dietary saturated fat will lead to positive health outcomes.
Dietary carbohydrate and health outcomes
The data in Figure 1 show that the increase in calories during the previous 30 y is almost entirely due to carbohydrate. The effectiveness of carbohydrate restriction for weight loss and improved markers of chronic disease when compared in head-to-head trials with low-fat diets continues to be newsworthy. With the established biochemistry of the glucose–insulin axis, dietary carbohydrate is a topic of increasing relevance to a public battling obesity and diabetes.
The DGAC Report describes it thus:
The results of their evidence review were conclusive: “No detrimental effects of carbohydrates as a source of calories on these or other health outcomes were reported” (p. D5-1). The evidence is not discussed, however, and there is no further debate regarding carbohydrates per se.
Dietary fiber and whole grains: Conclusions do not reflect the quantity and/or quality of science
The section on carbohydrate begins its evaluation of dietary carbohydrates with the question, “What are the health benefits of fiber?,” a question that presumes that health benefits have already been established. In fact, evidence supporting the health benefits of fiber with regard to obesity, diabetes, and bowel health is limited, as acknowledged in the American Dietetics Association (ADA) position paper on which much of the fiber information in the DGAC Report is based [63].
The ADA position paper also found:
The ADA library provides summary worksheets used to reach this conclusion; most of the summarized studies are funded by industry, as is the study published in 2009 by De Moura et al. [64] on whole grains cited by the DGAC Report (p. D5-9). This is not an inherent criticism of the conclusions, but the DGAC Report expresses concern about the influence of industry on studies pertaining to eggs and cholesterol (p. D3-47); no concern is voiced in regard to whole grains or fiber. The study by De Moura et al., ironically, shows that if the Food and Drug Administration definition of whole grain is used, there is insufficient scientific evidence to support a claim that whole grain intake decreases the risk of CVD, in direct contradiction of the DGAC Report’s conclusion (p. D5-11). A fundamental flaw in the DGAC Report’s support of whole grain and fiber intake is that these terms are defined inconsistently, and their definitions appear to be shaped to promote processed carbohydrate foods as “healthy.”
Glycemic load/index: Answers based on an incomplete body of relevant science
Based on the same physiologic principle as total carbohydrate decreases, the glycemic index (GI) and the glycemic load (GL) were designed to measure the impact of food on blood glucose levels. In practice, the GI/GL cannot always be reproduced consistently from person to person or even in the same person at different times. Glycemic impact can vary with a food’s ripeness, physical form, preparation, and foods with which it is consumed; research discussing the limitations of the GI/GL is not noted in the DGAC Report [65], [66]. The GI/GL is frequently proposed as an alternative to carbohydrate restriction, although the literature is clear that total carbohydrate intake has a more significant and consistent effect on glucose, insulin levels, and markers of CVD. Most recently, Westman et al. [67] compared a very low-carbohydrate diet with a diet based on the GI (Fig. 3). The GI-based diet had been shown by Jenkins et al. [68] to be superior to the kind of high-fiber diet recommended by the DGAC Report. Comparison of the two trials (Fig. 3) shows the low-carbohydrate diet to be more effective at controlling hemoglobin A1c and improving markers of cardiovascular risk. With regard to T2D, a high-cereal diet has limited benefits. A GI-based diet is better, but a low-carbohydrate diet has the most beneficial impact.

Fig. 3
Comparison of a high-cereal diet and two low-GI diets with a very-low-carbohydrate diet. CHO, carbohydrate; GI, glycemic index; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triacylglycerol; total-C, total cholesterol.
Data from Jenkins et al. [68] and Westman et al. [67].
The DGAC Report proposes to investigate the relation between the GI/GL and chronic diseases such as CVD and diabetes (p. D5-21) although the NEL “Search Plan and Results” excluded studies whose participants were diagnosed with either condition, including 24 studies on the effect of the GI/GL on participants with T2D. The experimentally established association between carbohydrate intake and diabetes, with improved glycemic control being positively related to decreased carbohydrate intake, suggests this is a serious flaw.
Type 2 diabetes mellitus is fundamentally a disease of carbohydrate metabolism. The repeated demonstration that an increase in the absolute amount of digestible carbohydrates is detrimental to glucose control makes the DGAC Report’s continued emphasis on grains especially troubling. According to the DGAC Report:
In essence, the public is being told that decreasing carbohydrates is not advisable because it would necessarily restrict fiber intake, although support for the benefits of fiber intake is limited and inconclusive. We are expected to accept, without substantial evidence or a clear biological mechanism, that an increase in fiber intake from 15 to 25 g/d will be more beneficial to a person with T2D than a decrease in the overall digestible carbohydrate content of the diet.
Dietary protein and health outcomes
For the first time, the DGAC Report makes the case for protein as the most important macronutrient in the diet (pp. D4-1, 3). The DGAC Report establishes the role of protein and protein quality in human health, discussing the essentiality of nine amino acids, which must be obtained from the diet, and the conditional essentiality of another six, pointing out that a dietary source of these amino acids may also be necessary (p. D4-1). The DGAC Report concludes that:
Although animal sources provide the highest-quality protein, Americans are advised to shift to a more “plant-based” diet (p. B3-3) and “consume only moderate amounts of lean meats, poultry, and eggs” (A2).
Animal versus plant protein: Recommendations do not reflect limitations and uncertainties of the science
The DGAC Report explores a possible relation between the intake of animal protein products and CHD, CVD, T2D, and prostate, colorectal, and breast cancers. The DGAC Report concludes that 1) moderate evidence found no clear association between intake of animal protein products and blood pressure, 2) limited inconsistent evidence suggests that mainly processed meat may have a link to T2D, 3) there is insufficient evidence to link animal protein to body weight, 4) there are inconsistent positive associations between colorectal cancer and intake of, mainly, red and processed meat, 5) there is limited evidence that animal protein products are associated with prostate cancer incidence, and 6) there is limited evidence that shows no association between intake of animal protein products and overall breast cancer risk (p. D4-6).
Despite concluding that the evidence is “moderate, limited, insufficient and inconsistent” on any relation between animal protein consumption and negative health outcomes and at the same time asserting that animal sources provide the highest-quality proteins, the DGAC Report cautions Americans about the increased animal protein content of their diets. The two main considerations are the quantity/quality/preparation of animal protein foods and the fact that animal protein contains saturated fat (p. D4-6). The concern about an inherent increase in saturated fat implies that dietary SFA are associated with health risks, which, as above, has not been demonstrated, and requires that a direct effect of animal protein on CVD, CHD, elevated cholesterol levels, and other chronic-disease markers can be demonstrated. In direct studies where protein intake is increased, particularly if accompanied by a decrease in total carbohydrate, markers for CVD and CHD are improved, hemoglobin A1c is decreased, and blood glucose and insulin levels are normalized [69], [70], [71], [72], [73], [74]. Concerns are raised that fat associated with animal protein may increase calorie levels (p. D4-6) but similar concerns are raised about plant-based proteins: “Plant products can be combined to improve protein quality, but the number of calories that must be consumed to get adequate intakes must be considered” (p. D4-3).
The DGAC Report acknowledges that plant protein confers no specific health benefits (p. D4-11) and may in fact present nutritional inadequacies (p. D4-16). The argument for the importance of protein in the diet is convincing but insufficient evidence to support the substitution of plant sources of protein is presented.
Salt: Recommendations do not reflect limitations and uncertainties of the science
There is probably no more telling example of the limitations of the DGAC Report than the recommendations on salt. The DGAC Report states that a “strong body of evidence has documented that in adults, as sodium intake decreases, so does blood pressure” (p. D6-2). Strong evidence is what is needed to make dietary recommendations but that evidence is lacking. A Cochrane review, for example, concluded that “intensive interventions, unsuited to primary care or population prevention programs, provide only minimal reductions in blood pressure during long-term trials” [75]. Another recent meta-review questioned the sustainability of the blood pressure–lowering effect over time [76]. Further evaluations to assess effects on morbidity and mortality outcomes are needed for populations as a whole and for patients with elevated blood pressure [77].
This is not to say that there is no evidence for decreases of salt intake but a major review would not express doubts or call for more study if the body of evidence in favor of restrictions was genuinely strong. Stepping back, we have to ask what general feature of the health profile of the country is being addressed by a call for a decrease in salt consumption; some fraction of the population has hypertension, and they are or should be counseled to be in the care of a physician who can offer dietary advice and medication.
The case for dietary reduction emphasizes the salt added to food in processing by manufacturers (pp. D6-3, D6-18). However, salt lost from food losses and wastage has never been quantified and may amount to anywhere from 27% to 50% [78], [79]. By design, many foods and food-manufacturing processes use considerably more salt than the final consumer ingests. As a result, there is no accurate assessment of the amount and sources of salt actually consumed.
The DGAC Report brings up relevant points on salt consumption that may be significant for Americans with moderate renal impairment and hypertension, conditions that are increasing in parallel with insulin resistance and the metabolic syndrome. However, the current sweeping recommendations for population-wide sodium restrictions that disregard uncertainties in the science and variations in individuals may undermine the public’s confidence in those recommendations, which are of unquestioned value.
Summary: What can be done?
Is there nothing of value in the DGAC Report? On the contrary, there are valuable suggestions made regarding improving nutritional literacy and cooking skills; restructuring the food environment, including farmers, agricultural producers, and food manufacturers; and improving the availability of affordable fresh produce. However, none of these recommendations makes sense in the context of nutritional guidance that is not based on sound scientific principles and demonstrable results. Reforming the food environment must begin with a re-evaluation of 30 y of nutritional policy that was originally implemented without a thorough and unbiased evaluation of the science.
It is of interest to consider the opinion of the American Medical Association (AMA) with respect to the first implementation of dietary guidelines [80]. In an editorial, it was stated:
The guidelines recommended at that time show great similarity to the current recommendations:
In the three decades since, carbohydrate consumption has increased; overall fat, saturated fat, and cholesterol consumption have decreased to near or below targeted levels; caloric intake remains within recommended levels; and leisure-time physical activity has increased slightly (pp. D1-1, D3-10, B2-3). At the same time, scientific evidence in favor of these recommendations remains inconclusive, and we must consider the possibility that the “potential for harmful effects” has in fact been realized. Notably, “the prevalence of overweight and obesity in the US has increased dramatically in the past three decades” (A4); the number of Americans diagnosed with T2D has tripled [81].
The AMA concludes:
Laudable as the goals were, the application of those recommendations has constituted a population-wide dietary experiment that should be brought to a halt. Lack of supporting evidence limits the value of the proposed recommendations as guidance for the consumer or as the basis of public health policy. We ask whether the Dietary Guidelines for Americans process as it stands should continue or whether there might not be better alternatives.
It is time for public health leaders, scientists, and clinicians to stop blaming Americans for not following the recommendations in the Dietary Guidelines for Americans and instead to re-examine the process used to formulate the US dietary guidelines and determine whether or not it is still appropriate for our current needs.
We ask whether it would be preferable to convene an impartial panel of scientists consisting of biochemists, anthropologists, geneticists, physicists, etc., who are not directly tied to nutritional policy. Such a panel would be able to hear all sides in the debate with few preconceived notions. Recommendations issued by this group would be more likely to be moderate, circumspect, and established on a complete and accurate assessment of available science rather than a narrow perspective of accepted nutritional practice. Public health nutritional policies produced from such recommendations may then serve the honorable intentions of those first dietary goals “to maximize the quality of life for all Americans” [5].
Acknowledgments
The authors are grateful to Dr. Alan Titchenal and Dr. Joannie Dobbs of the University of Hawaii for valuable discussion and suggestions.
References
- . Effect of dietary carbohydrate on the metabolism of patients with non-insulin dependent diabetes mellitus. Nutr Rev. 1986;44:65–73
- . Diet, nutrition and cancer: public, media and scientific confusion. Ann Oncol. 2008;19:1665–1667
- . Eating made simple. Sci Am. 2007;297:60–69
- US Department of Agriculture and US Department of Health and Human Services. Report of the Dietary Guidelines Advisory Committee on the dietary guidelines for Americans, 2010. June 15, 2010. Available at: http://www.cnpp.usda.gov/DGAs2010-DGACReport.htm. Accessed on August 31, 2010.
- . Dietary goals for the United States. 2nd ed.. Washington, DC: US Government Printing Office; 1977;
- . Trends in intake of energy and macronutrients—United States, 1971–2000. Morb Mortal Wkly Rep. 2004;53:80–82Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5304a3.htm. Accessed on August 30, 2010
- . Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington, DC: National Academies Press; 2005;
- Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2009;32:959–965
- . The metabolic response to a high-protein, low-carbohydrate diet in men with type 2 diabetes mellitus. Metab Clin Exp. 2006;55:243–251
- A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med. 2004;117:398–405
- . Effect of high-carbohydrate or high–cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials. Am J Clin Nutr. 2007;85:1251–1256
- . Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009;136:1552–1560
- . Effects of moderate variations in the macronutrient content of the diet on cardiovascular disease risk factors in obese patients with the metabolic syndrome. Am J Clin Nutr. 2007;86:946–951
- Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women. J Am Coll Nutr. 2004;23:177–184
- Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44:297–309
- . Effects of hypocaloric very-low-carbohydrate diet vs. Mediterranean diet on endothelial function in obese women. Eur J Clin Invest. 2009;39:339–347
- Low- and high-carbohydrate weight-loss diets have similar effects on mood but not cognitive performance. Am J Clin Nutr. 2007;86:580–587
- . Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87:567–576
- . Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev. 2009;10:36–50
- Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:285–293
- Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359:229–241
- . Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr. 2008;87:44–55
- . Anthropometric and leptin changes in women following different approaches to weight loss. Obesity (Silver Spring). 2009;17:199–201
- . Perceived hunger is lower and weight loss is greater in overweight premenopausal women consuming a low-carbohydrate/high-protein vs high-carbohydrate/low-fat diet. J Am Diet Assoc. 2005;105:1433–1437
- . A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004;140:769–777
- Weight loss study: a randomized trial among overweight premenopausal women: the A to Z diets for change in weight and related risk factors. Comparison of the Atkins, Zone, Ornish, and LEARN. JAMA. 2007;297:969–977
- A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003;348:2074–2081
- . Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43–53
- . A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003;88:1617–1623
- A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;348:2082–2090
- . Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol. 2008;51:59–67
- Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med. 2007;261:366–374
- . Low-carbohydrate-high-protein diet and long-term survival in a general population cohort. Eur J Clin Nutr. 2007;61:575–581
- A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol. 2009;8:36
- Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia. 2005;48:8–16
- . Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009;90:23–32
- . Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83:1025–1031
- Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance. J Am Diet Assoc. 2009;109:713–717
- . Short-term changes in lipoprotein subclasses and C-reactive protein levels of hypertriglyceridemic adults on low-carbohydrate and low-fat diets. Nutr Res. 2008;28:443–449
- . Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res. 2008;47:307–318
- . Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr. 2010;91:502–509
- Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43:65–77
- . The role of energy expenditure in the differential weight loss in obese women on low-fat and low-carbohydrate diets. J Clin Endocrinol Metab. 2005;90:1475–1482
- A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss. Arch Intern Med. 2010;170:136–145
- Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611–1620
- Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans. Am J Clin Nutr. 2004;80:1145–1158
- . Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport. J Lipid Res. 2008;49:2414–2418
- . Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr. 2005;82:957–963
- Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425–1432
- . Clinical practice recommendations 2010. Diabetes Care. 2010;33:S11–S61
- . Effect of the dietary fat quality on insulin sensitivity. Br J Nutr. 2008;100:471–479
- . Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 2001;44:805–817
- Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–1679
- High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia. 2006;49:912–920
- A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007;26:434–444
- . Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr. 2008;88:638–644
- . Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes. Diabetes Care. 2007;30:2993–2998
- . Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord. 2003;27:95–102
- Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism. 2007;56:985–991
- A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia. 2001;44:2038–2043
- Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001;73:1019–1026
- Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001;44:312–319
- . Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716–1731
- . Applying the FDA definition of whole grains to the evidence for cardiovascular disease health claims. J Nutr. 2009;139:2220S–6
- . The glycemic index: methodological aspects related to the interpretation of health effects and to regulatory labeling. J AOAC Int. 2009;92:879–887
- . Glycemic index and disease. Am J Clin Nutr. 2002;76:290S–8
- . The effect of a low-carbohydrate ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond). 2008;5:36
- Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA. 2008;300:2742–2753
- . Foster PR, Clifton PM. Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr. 2005;81:1298–1306
- . Increased dietary protein modifies glucose and insulin homeostasis in adult women during weight loss. J Nutr. 2003;133:405–410
- . Metabolic response of people with type 2 diabetes to a high protein diet. Nutr Metab. 2004;1:6–12
- . An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr. 2003;78:734–741
- . Partial substitution of carbohydrate intake with protein intake from lean red meat lowers blood pressure in hypertensive persons. Am J Clin Nutr. 2006;83:780–787
- . Dietary protein impact on glycemic control during weight loss. J Nutr. 2004;134:968S–73
- . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev. 2004;CD003656
- Institute for Quality and Efficiency in Health Care. Executive summary of report A05-21B. Benefit assessment of non-drug treatment strategies in patients with essential hypertension: reduction in salt intake [Nutzenbewertung nichtmedikamentöser Behandlungsstrategien bei Patienten mit essenzieller Hypertonie: Kochsalzreduktion]; Cologne, Germany; June 18, 2009. Executive summary in English. Available at: http://www.iqwig.de/download/A05-21B_Executive_Summary_Non-drug_treatment_strategies_for_hypertension-reduction_in_salt_intake.pdf. Accessed August 30, 3010.
- . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglycerides. Cochrane Database Syst Rev. 2004;CD004022
- . Estimating and addressing America’s food losses. Food Rev. 1997;20:2–12
- . America wastes half its food. Futurist. 2005;39:12
- . Dietary goals for the United States: statement of the American Medical Association to the select committee on nutrition and human needs, United States Senate. R I Med J. 1977;60:576–581
- Centers for Disease Control and Prevention (CDC). National Center for Health Statistics, Division of Health Interview Statistics, data from the National Health Interview Survey. Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm. Accessed August 15, 2010.
PII: S0899-9007(10)00289-3
doi:10.1016/j.nut.2010.08.012
© 2010 Elsevier Inc. All rights reserved.

